La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Alibaba Health Information Technology Gestione
Gestione criteri di controllo 3/4
Alibaba Health Information Technology's Il CEO è Difan Shen, nominato in Nov2023, e ha un mandato di meno di un anno. la retribuzione annua totale è CN¥ 6.81M, composta da 25.2% di stipendio e 74.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.009% delle azioni della società, per un valore di HK$ 4.36M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2 anni e 2 anni.
Informazioni chiave
Difan Shen
Amministratore delegato
CN¥6.8m
Compenso totale
| Percentuale dello stipendio del CEO | 25.2% |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.009% |
| Durata media del management | 2.2yrs |
| Durata media del Consiglio di amministrazione | 2.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
What Does Alibaba Health Information Technology Limited's (HKG:241) Share Price Indicate?
Sep 23
Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Jul 03After Leaping 26% Alibaba Health Information Technology Limited (HKG:241) Shares Are Not Flying Under The Radar
Jun 07Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors
Jun 06Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%
Apr 21Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?
Apr 16Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger
Mar 29Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For
Jan 17Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?
Jan 07Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)
Dec 15Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price
Sep 28Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price
Jul 02Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Jun 11Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2024 | CN¥7m | CN¥2m | CN¥883m |
| Dec 31 2023 | n/a | n/a | CN¥851m |
| Sep 30 2023 | n/a | n/a | CN¥817m |
| Jun 30 2023 | n/a | n/a | CN¥675m |
| Mar 31 2023 | CN¥6m | CN¥1m | CN¥536m |
| Dec 31 2022 | n/a | n/a | CN¥332m |
| Sep 30 2022 | n/a | n/a | CN¥128m |
| Jun 30 2022 | n/a | n/a | -CN¥69m |
| Mar 31 2022 | CN¥6m | CN¥1m | -CN¥266m |
| Dec 31 2021 | n/a | n/a | -CN¥216m |
| Sep 30 2021 | n/a | n/a | -CN¥167m |
| Jun 30 2021 | n/a | n/a | CN¥91m |
| Mar 31 2021 | n/a | n/a | CN¥349m |
| Dec 31 2020 | n/a | n/a | CN¥313m |
| Sep 30 2020 | n/a | n/a | CN¥278m |
| Jun 30 2020 | n/a | n/a | CN¥136m |
| Mar 31 2020 | CN¥12m | CN¥2m | -CN¥7m |
| Dec 31 2019 | n/a | n/a | -CN¥3m |
| Sep 30 2019 | n/a | n/a | CN¥1m |
| Jun 30 2019 | n/a | n/a | -CN¥40m |
| Mar 31 2019 | CN¥7m | CN¥33k | -CN¥82m |
Compensazione vs Mercato: La retribuzione totale di Difan ($USD 971.79K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 1,000.00K ).
Compensazione vs guadagni: La retribuzione di Difan è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Difan Shen (46 yo)
less than a year
Mandato
CN¥6,814,000
Compensazione
Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | CN¥6.81m | 0.0089% CN¥ 8.1m | |
| CFO & Executive Director | 4.5yrs | CN¥5.34m | 0.0050% CN¥ 4.5m | |
| Legal Counsel & Joint Company Secretary | 1.8yrs | Nessun dato | Nessun dato | |
| Chief Marketing Officer | 2.6yrs | Nessun dato | Nessun dato | |
| Chief People Officer | 4.7yrs | Nessun dato | Nessun dato | |
| Financial Controller | no data | Nessun dato | Nessun dato | |
| Chief Legal Advisor & Joint Company Secretary | 1.2yrs | Nessun dato | Nessun dato |
2.2yrs
Durata media
Gestione esperta: Il team dirigenziale di 241 è considerato esperto (durata media dell'incarico 2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Director | 3yrs | CN¥6.81m | 0.0089% CN¥ 8.1m | |
| CFO & Executive Director | 4yrs | CN¥5.34m | 0.0050% CN¥ 4.5m | |
| Independent Non-Executive Director | 1.2yrs | CN¥411.00k | Nessun dato | |
| Independent Non-Executive Director | 5.3yrs | CN¥348.00k | Nessun dato | |
| Non-Executive Chairman of the Board | 4.6yrs | CN¥19.00m | 0.0086% CN¥ 7.7m | |
| Independent Non-Executive Director | 1.2yrs | CN¥223.00k | Nessun dato | |
| Non-Executive Director | 1.4yrs | Nessun dato | Nessun dato | |
| Non-Executive Director | less than a year | Nessun dato | Nessun dato |
2.2yrs
Durata media
48.5yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di 241 non è considerato esperto (durata media del mandato 2 anni), il che suggerisce un nuovo consiglio.